PTX 10.6% 4.2¢ prescient therapeutics limited

Ann: PTX-100 trial advances following successful Phase 1b, page-97

  1. 7,855 Posts.
    lightbulb Created with Sketch. 3351
    If you watch the interviews with Steve where he speaks of monetization and see the collaborations PTX have, I don't see a takeover of the company necessarily happening is it did with VLA.

    They mention fast-tracking PTX100 to registrations trials and commercialisation. VLA as a company did not have the calibre of management that PTX has or the support and collaborative structure this company has!

    Jip, I mentioned VLA because it got bought out for its solitary drug for half a billion dollars. PTX is WAY beyond what VLA was and has a platform that could revolutionise the oncology scene. 300% SP accretion could easily happen over a period of 12 mths... anything is possible in this sector.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.2¢
Change
-0.005(10.6%)
Mkt cap ! $33.82M
Open High Low Value Volume
4.7¢ 4.7¢ 4.2¢ $81.21K 1.844M

Buyers (Bids)

No. Vol. Price($)
1 11932 4.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.3¢ 50000 1
View Market Depth
Last trade - 15.57pm 26/08/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.